These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3546246)

  • 1. Comparative activity of imipenem, ceftazidime and cefotaxime against Acinetobacter calcoaceticus.
    Bergogne-Berezin E; Joly-Guillou ML
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():35-9. PubMed ID: 3546246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative activity in vitro of ceftizoxime, ceftazidime and imipenem against Acinetobacter calcoaceticus].
    Joly-Guillou ML; Bergogne-Bérézin E
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):625-8. PubMed ID: 3534756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative activity of imipenem, ceftazidime and cefotaxime against Acinetobacter calcoaceticus].
    Vallée E; Joly-Guillou ML; Bergogne-Berezin E
    Presse Med; 1990 Apr; 19(13):588-91. PubMed ID: 2139937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial properties of imipenem with special reference to the activity against methicillin-resistant staphylococci, cefotaxime-resistant Enterobacteriaceae and Pseudomonas aeruginosa.
    Vurma-Rapp U; Kayser FH; Barberis-Maino L
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():27-33. PubMed ID: 3102452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of antimicrobial agents against Acinetobacter calcoaceticus.
    Joly-Guillou ML; Bergogne-Berezin E
    Drugs Exp Clin Res; 1986; 12(12):949-52. PubMed ID: 3471431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of cefepime on ceftazidime, cefotaxime and imipenem resistant strains of Acinetobacter, Xanthomonas, Pseudomonas, Flavobacterium, Sphingobacterium and on producers of extended spectrum beta-lactamases (ESBL) with resistance transfer].
    Blahová J; Hupková-Lesická M; Králiková K; Krcméry V; Kubonová K
    Cas Lek Cesk; 1997 Mar; 136(5):154-6. PubMed ID: 9221190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ro 17-2301: in vitro comparison with aztreonam, imipenem, ceftazidime, cefotaxime and netilmicin.
    Digranes A; Dibb WL; Benonisen E; Salveson A
    Chemotherapy; 1985; 31(4):279-85. PubMed ID: 3928281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro activity of ceftazidime compared with five beta-lactamase stable compounds against clinical strains of Acinetobacter calcoaceticus ].
    Bergogne-Berezin E; Joly-Guillou ML; Verin-Prevost C
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):506-9. PubMed ID: 6289227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro antibacterial activity of imipenem compared with four other beta-lactam antibiotics (ceftazidime, cefotaxime, piperacillin and azlocillin) against 828 separate clinical isolates from a Portuguese hospital.
    Santos-Ferreira MO; Vital JO
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():23-6. PubMed ID: 3469195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of imipenem towards gram-negative bacilli.
    Speciale A; Caccamo F; Pellegrino MB; Blandino G; Nicoletti G
    Chemioterapia; 1986 Oct; 5(5):291-6. PubMed ID: 3466723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of the Acinetobacter calcoaceticus-A. baumannii complex to imipenem, meropenem, sulbactam and colistin.
    Dueñas Díez AI; Bratos Pérez MA; Eiros Bouza JM; Almaraz Gómez A; Gutiérrez Rodríguez P; Miguel Gómez MA; Orduña Domingo A; Rodríguez-Torres A
    Int J Antimicrob Agents; 2004 May; 23(5):487-93. PubMed ID: 15120728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activity and beta-lactamase stability of CGP 31523A, a new aminothiazolyl cephalosporin.
    Chin NX; Neu HC
    Chemioterapia; 1986 Apr; 5(2):92-100. PubMed ID: 3518967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative in vitro study of the activity of 5 quinolones against Acinetobacter calcoaceticus].
    Joly-Guillou ML; Bergogne-Berezin E
    Pathol Biol (Paris); 1985 May; 33(5):416-20. PubMed ID: 3162142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli].
    Thabaut A; Meyran M; Huerre M
    Pathol Biol (Paris); 1985 May; 33(5):404-7. PubMed ID: 3929217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of N-formimidoyl thienamycin, ceftazidime, cefotiam, ceftriaxone and cefotaxime on non-fermentative Gram-negative rods, Aeromonas, Plesiomonas and Enterobacter agglomerans.
    von Graevenitz A; Bucher C
    Infection; 1982; 10(5):293-8. PubMed ID: 6293976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tentative interpretive criteria for in vitro antibacterial susceptibility testing with imipenem.
    Shungu DL; Cerami AT; Weinberg E; Capizzi T; Gadebusch HH
    J Clin Microbiol; 1986 Mar; 23(3):421-4. PubMed ID: 3514655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multicenter study of the in vitro effect of imipenem (N-formimidoyl-thienamycin) on hospital bacteria].
    Soussy CJ; Otterbein G; Le Van Thoi J; Thabaut A; Meyran M; Courtieu AL; Reynaud A; Dabernat H; Lareng MB; Chanal M
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):487-92. PubMed ID: 3911142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Selection of resistance mutants and bacteriostatic and bactericidal activity of meropenem and imipenem against Acinetobacter spp].
    Villar HE; Laurino G; Arena MF; Hoffman M
    Enferm Infecc Microbiol Clin; 1997 Mar; 15(3):140-3. PubMed ID: 9235053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro antibacterial activity and beta-lactamase stability of meropenem].
    Poiată A; Tuchiluş C; Bădicuţ I; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):589-94. PubMed ID: 14756067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum beta-lactamases.
    Chanal C; Sirot D; Chanal M; Cluzel M; Sirot J; Cluzel R
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():133-41. PubMed ID: 2808205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.